BridgeMD
Prevention study for Surgical Site Infection
Official title Local Subcutaneous Gentamicin for Prevention of Surgical Site Infection After Elective Cesarean Section
ClinicalTrials.gov ID: NCT07311395
What this study is testing
What is Gentamicin?
Gentamicin is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for surgical site infection.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to evaluate whether local subcutaneous administration of gentamicin reduces the incidence of surgical site infection (SSI) following elective cesarean section. The study will also assess the safety of local gentamicin administration.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Women aged 18 years and older.
- Undergoing elective cesarean section.
- Gestational age \>= 24 weeks.
- Planned postoperative follow-up of 30 days.
- Eligible for standard antibiotic prophylaxis according to institutional protocol.
You likely can't join if
- Known allergy of hypersensitivity to aminoglycosides.
- Known allergy of hypersensitivity to systemic antibiotic prophylaxis agents.
- Current or planned use of immunomodulatory or immunosuppressive therapy.
- Requirement for therapeutic ( non- prophylactic) antibiotic treatment at the time of surgery.
- Active infection or clinical condition requiring antibiotic treatment.
- Inability or unwillingness to comply with study procedures or follow-up.
See the full eligibility criteria
- Women aged 18 years and older.
- Undergoing elective cesarean section.
- Gestational age \>= 24 weeks.
- Planned postoperative follow-up of 30 days.
- Eligible for standard antibiotic prophylaxis according to institutional protocol.
- Able to provide informed consent.
- Known allergy of hypersensitivity to aminoglycosides.
- Known allergy of hypersensitivity to systemic antibiotic prophylaxis agents.
- Current or planned use of immunomodulatory or immunosuppressive therapy.
- Requirement for therapeutic ( non- prophylactic) antibiotic treatment at the time of surgery.
- Active infection or clinical condition requiring antibiotic treatment.
- Inability or unwillingness to comply with study procedures or follow-up.
The study team makes the final eligibility decision.
Where it's taking place
- Nahariya, Israel
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nahariya, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.